Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2001-12-31
2004-03-30
Park, Hankyel T. (Department: 1648)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C530S350000
Reexamination Certificate
active
06713281
ABSTRACT:
The present invention relates to enzymes, particularly to thermostable enzymes. More particularly, the present invention relates to thermostable enzymes which are stable at high temperature and which have improved activity at lower temperatures.
Thermostable enzymes are enzymes that function at greater than 60° C. Thermostable enzymes are utilized in both industry and biomedical research in assays where certain steps of the assay are performed at significantly increased temperatures. Thermostable enzymes may be obtained from thermophilic organisms found in hot springs, volcanic origin, tropical areas etc. Examples of such organisms, for instance, include prokaryotic microorganisms, such as eubacteria and archaebacteria (Bronneomerier, K. and Staudenbauer, W. L., D. R. Woods (ed), the Clostridia and Biotechnology, Butterworth Publishers, Stoneham, M. A. (1993), among other organisms.
Thermostable enzymes exhibit greater storage life capacity and organic solvent resistance, as compared to their mesophilic counterparts.
There are applications in industry and in research for thermostable enzymes which exhibit enzyme activity at a desired minimum temperature. An example of this occurs in molecular diagnostics wherein reporter molecules must survive long term storage at room temperature or higher or they need to function in unusual environments, and the assays which employ them are performed at room temperature where the activity of thermostable enzymes is generally very low.
REFERENCES:
patent: 4683202 (1987-07-01), Mullis
patent: 4800159 (1989-01-01), Mullis et al.
patent: 4959312 (1990-09-01), Sirotkin
patent: 4965188 (1990-10-01), Mullis et al.
patent: 5096815 (1992-03-01), Ladner et al.
patent: 5176995 (1993-01-01), Sninsky et al.
patent: 5187083 (1993-02-01), Mullis
patent: 5198346 (1993-03-01), Ladner et al.
patent: 5223408 (1993-06-01), Goeddel et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5234824 (1993-08-01), Mullis
patent: 5333675 (1994-08-01), Mullis et al.
patent: 5352778 (1994-10-01), Comb et al.
patent: 5354656 (1994-10-01), Sorge et al.
patent: 5389537 (1995-02-01), Raines et al.
patent: 5500363 (1996-03-01), Comb et al.
patent: 5512463 (1996-04-01), Stemmer
patent: 5605793 (1997-02-01), Stemmer
patent: 5645988 (1997-07-01), Vande Woude et al.
patent: 5658727 (1997-08-01), Barbas et al.
patent: 5723323 (1998-03-01), Kauffman et al.
patent: 5759817 (1998-06-01), Barbas
patent: 5763192 (1998-06-01), Kauffman et al.
patent: 5789166 (1998-08-01), Bauer et al.
patent: 5798208 (1998-08-01), Crea
patent: 5811238 (1998-09-01), Stemmer et al.
patent: 5814476 (1998-09-01), Kauffman et al.
patent: 5817483 (1998-10-01), Kauffman et al.
patent: 5824469 (1998-10-01), Horwitz et al.
patent: 5824485 (1998-10-01), Thompson et al.
patent: 5824514 (1998-10-01), Kauffman et al.
patent: 5830696 (1998-11-01), Short
patent: 5830721 (1998-11-01), Stemmer et al.
patent: 5837458 (1998-11-01), Minshull et al.
patent: 5866363 (1999-02-01), Pieczenik
patent: 5885577 (1999-03-01), Alvarez
patent: 5885827 (1999-03-01), Wabl et al.
patent: 5932419 (1999-08-01), Bauer et al.
patent: 5945329 (1999-08-01), Breddam et al.
patent: 5965408 (1999-10-01), Short
patent: 5976862 (1999-11-01), Kauffman et al.
patent: 6004788 (1999-12-01), Short
patent: 6054267 (2000-04-01), Short
patent: 6057103 (2000-05-01), Short
patent: 6171820 (2001-01-01), Short
patent: 6238884 (2001-05-01), Short et al.
patent: 6335179 (2002-01-01), Short
patent: 6352842 (2002-03-01), Short et al.
patent: 6358709 (2002-03-01), Short et al.
patent: 6361974 (2002-03-01), Short et al.
patent: 0 285 123 (1988-10-01), None
patent: 0 316 018 (1989-05-01), None
patent: WO 90/02809 (1990-03-01), None
patent: WO 91/12341 (1991-08-01), None
patent: WO 91/16427 (1991-10-01), None
patent: WO 95/20039 (1995-07-01), None
patent: WO 95/22625 (1995-08-01), None
patent: WO 96/06188 (1996-02-01), None
patent: WO 96/09411 (1996-03-01), None
patent: WO 96/41865 (1996-12-01), None
patent: WO 97/20078 (1997-06-01), None
patent: WO 97/20950 (1997-06-01), None
patent: WO 97/35957 (1997-10-01), None
patent: WO 98/01581 (1998-01-01), None
patent: WO 98/13487 (1998-04-01), None
patent: WO 98/27230 (1998-06-01), None
patent: WO 98/32845 (1998-07-01), None
patent: WO 98/38297 (1998-09-01), None
patent: WO 98/42832 (1998-10-01), None
patent: WO 98/45331 (1998-10-01), None
patent: WO 98/48024 (1998-10-01), None
patent: WO 98/49286 (1998-11-01), None
patent: WO 98/58080 (1998-12-01), None
patent: WO 99/36553 (1999-07-01), None
patent: WO 00/52146 (2000-09-01), None
patent: WO 00/52153 (2000-09-01), None
patent: WO 00/52155 (2000-09-01), None
patent: WO 00/52180 (2000-09-01), None
patent: WO 01/30998 (2001-05-01), None
patent: WO 01/31035 (2001-05-01), None
patent: WO 01/31049 (2001-05-01), None
patent: WO 01/42455 (2001-06-01), None
Arkin and Youvan, “Optimizing nucleotide mixtures to encode specific subsets of amino acids for semi-radom mutagenesis,”Bio-technology(NY) 10(3):297-300 (Mar. 1992).
Burks et al., “In-vitro scanning saturation mutagenesis of an antibody binding pocket,”Proc Natl Acad Sci USA94(2): 412-417 (Jan. 21, 1997).
Chen and Struhl, “Saturation mutagenesis of a yeast hls3“TATA element”: genetic evidence for a specific TATA-binding protein,”Proc Natl Acad Sci USA85(8):2691-2695 (Apr. 1988).
Chiang et al., “Mutagenic oligonucleotide-directed PCR amplification (Mod-PCR): an efficient method for generation random base substitution in a DNS sequence element,”PCR Methods Appl2(3): 210-217 (Feb. 1993).
Christian et al, “Simplified methods for construction, assessment and rapid screening of peptide libraries in bacteriophage,”J Mol Biol227(3):711-718 (Oct. 5, 1992).
Cunniff and Mrogan, “Analysis of heat shock element recognition by saturation mutagenesis of the humanHSP70.1gene promoter,” J. Biol Chem 268(11):8317-8324 (Apr. 15, 1993).
Cwirla et al., “Peptide on a phage: a vast library of peptides for identifying ligands,”Proc Natl Acad Sci USA87(16): 6378-6382 (Aug. 1990).
Delagrave and Youvan, “Searching Sequence Space to Engineer Proteins: Exponential Ensemble Mitagenesis,”Bio/Technology, 11:1548-1552 (Dec. 1993).
Dennis and Lazarus, “Kunitz domain inhibitors of tissue factor-factor Vlla. I. Potent inhibitors selected from libraries by phage display,”J Biol Chem269(35): 22129-22136 (Sep. 2, 1994).
Derbyshire et al., “A Simple and efficient procedure for saturation mutagenesis using mixed oligodeoxynucleotides,”Gene46(2-3): 145-152 (1986).
Goff et al., “Efficient saturation mutagenesis of a pentapeptide coding sequence using mixed oligonucleotides,”DNA6(4): 381-388 (Aug. 1987).
Hill and Struhl, “Mutagenesis with degenerate oligonucleotides: and efficient method for saturating a defined DNA region with base pair substitutions,”Methods Enzymol155:558-568 (1987).
Horwitz and DiMaio, “Saturation mutagenesis using mixed oligonucleotides and M13 templates containing uracil,”Methods Enzymol185: 599-611 (1990).
Ihara et al., Requirement of the Pro-Cys-His-Arg sequence for O6-methylguanine DNA methylransferase activity revealed by saturation mutagenesis with negative and positive screening,Mol Gen Genet243(4): 379-389 (May 25, 1994).
J.W. Little, “Saturation mutagenesis of specific codons: elimination of molecule with stop codons from mixed pools of DNA,”Gene88(1): 113-115 (Mar. 30, 1990).
Morris and McIvor, “Saturation mutagenesis at dihydrofolate reductase codons 22 and 31. A variety of amino acid substitutions conferring methotrexate resistance,”Biochem Pharmacol47(7): 1207-1220 (Mar. 29, 1994).
Olesen and Kielland-Brandt, “Altering substrate preference of carboxypeptidase Y by a novel strategy of mutagenesis eliminating wild type backgroun, ”Protein Eng6(4): 409-415 (Jun. 1993).
Olins et al., “Saturation mutagenesis of human interleukin-3,”J Biol Chem270(40): pp 23754-123760 (Oct. 6, 1995).
Oliphant and Struhl, “An efficient method for generation proteins with altered enzymatic properties: application to beta-lactamase,”Proc Natl Acad Sci USA88(23):9094-9098 (Dec. 1989).
Oliphant et al., “Cloning of random-sequence oligodeoxynucleotides,”Gene44
Diversa Corporation
Hale and Dorr LLP
Love Jane M.
Park Hankyel T.
LandOfFree
Directed evolution of thermophilic enzymes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Directed evolution of thermophilic enzymes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Directed evolution of thermophilic enzymes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3191007